Cargando…

Time to dementia diagnosis by race: A retrospective cohort study

BACKGROUND: Non‐Hispanic Black individuals may be less likely to receive a diagnosis of dementia compared to non‐Hispanic White individuals. These findings raise important questions regarding which factors may explain this observed association and any differences in the time to which disparities eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Matthew A., Lee, Kathryn A., Harris, Melissa, Ha, Jinkyung, Langa, Kenneth M., Bynum, Julie P. W., Hoffman, Geoffrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Ethnogeriatrics and Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669160/ https://www.ncbi.nlm.nih.gov/pubmed/36200557 http://dx.doi.org/10.1111/jgs.18078

Ejemplares similares

Medicare spending associated with a dementia diagnosis among older adults
por: Hoffman, Geoffrey J., et al.
Publicado: (2022)

Caregiving Intensity and Depressive Symptoms Among Older Adults After Partners’ Onset of Dementia
por: Harris, Melissa, et al.
Publicado: (2021)

Improvements in ECG accuracy for diagnosis of left ventricular hypertrophy in obesity
por: Rider, Oliver J, et al.
Publicado: (2016)

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
por: Hippisley-Cox, Julia, et al.
Publicado: (2020)

Influence of Renal Function on Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Romosozumab
por: Hsu, Cheng‐Pang, et al.
Publicado: (2022)

Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
por: Alencherry, Ben, et al.
Publicado: (2019)

The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
por: Ashton, Veronica, et al.
Publicado: (2021)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function
por: Sane, Rucha, et al.
Publicado: (2021)

Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
por: Wang, Ellen Q., et al.
Publicado: (2021)

Cardiovascular disease recurrence and long-term mortality in a tri-ethnic British cohort
por: Vyas, Manav V, et al.
Publicado: (2021)

Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study
por: Newton, Julia L, et al.
Publicado: (2016)

Long QT syndrome is associated with an increased burden of diabetes, psychiatric and neurological comorbidities: a nationwide cohort study
por: Marstrand, Peter, et al.
Publicado: (2019)

Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
por: Zahir, Hamim, et al.
Publicado: (2022)

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
por: Matli, Kamal, et al.
Publicado: (2021)

Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment
por: Xu, Yan, et al.
Publicado: (2022)

Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
por: Bækdal, Tine A., et al.
Publicado: (2018)

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
por: Hodes, Anke R, et al.
Publicado: (2016)

Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension
por: Stott, D, et al.
Publicado: (2016)

Single‐Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment
por: Dudkowski, Caroline, et al.
Publicado: (2017)

Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2019)

Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics
por: Trueman, Sheryl, et al.
Publicado: (2019)

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry
por: Apenteng, Patricia, et al.
Publicado: (2023)

Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity
por: Gille, Andreas, et al.
Publicado: (2018)

Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction
por: Stirrat, Colin G, et al.
Publicado: (2017)

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
por: Sahasrabudhe, V., et al.
Publicado: (2017)

Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study
por: Tomas, Cara, et al.
Publicado: (2017)

Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites
por: Wang, Ellen Q., et al.
Publicado: (2022)

Subtle increases in heart size persist into adulthood in growth restricted babies: the Cardiovascular Risk in Young Finns Study
por: Arnott, Clare, et al.
Publicado: (2015)

Disparity in spatial distribution of pericardial calcifications in constrictive pericarditis
por: Senapati, Alpana, et al.
Publicado: (2018)

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment
por: Hoover, Randall, et al.
Publicado: (2016)

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience
por: Batra, Akshee, et al.
Publicado: (2021)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Access to Medicaid and Medicare by the low-income disabled
por: Ellwood, Marilyn Rymer, et al.
Publicado: (1990)

Medicaid-financed residential care for persons with mental retardation
por: Lakin, K. Charlie, et al.
Publicado: (1990)

Medicaid mysteries: Transitional benefits, Medicaid coverage, and welfare exits
por: Ellwood, David T., et al.
Publicado: (1990)

Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis
por: Gaze, David C, et al.
Publicado: (2014)

Heart rate variability analysis during head-up tilt test predicts nitroglycerine-induced syncope
por: Efremov, Kristian, et al.
Publicado: (2014)

Pharmacokinetics of the Dual Melatonin Receptor Agonist Tasimelteon in Subjects With Hepatic or Renal Impairment
por: Torres, Rosarelis, et al.
Publicado: (2015)

Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease
por: Nelson, Alexander, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cpkt4rt31a65252fcjn7pq2hf2